Furthermore, there was a significative and progressive reduction in the expression of CD16, a marker for NK activation, and CD69, a marker of activation and tissue residency, in NKbright cells (Figures 6C, D) with BCLC stage in the surrounding non-tumoral HCC area. Here, CD69 is linked to hepatocellular carcinoma.